About Ignite Proteomics
For Physicians
For BioPharma Partners
For Physicians
Our 32-analyte assay will assist the treating physician in a data-driven process for treatment decision support and enable new predictive protein biomarker-based selection
For Investors
For BioPharma Partners
For Physicians
From Press Releases to Stock Quotes, everything you need to know can be found here.
For BioPharma Partners
For BioPharma Partners
For BioPharma Partners
Pathway-based assessment of the activated proteome using Reverse Phase Protein Array (RPPA) and laser capture microdissection (LCM) to support therapeutic development in oncology and immuno-oncology from discovery through clinical trials.